The impact of early de novo donor-specific antibodies on lung transplant outcomes: Is timing everything?

被引:1
作者
King, Christopher S. [1 ]
Cochrane, Adam B. [2 ]
机构
[1] Inova Fairfax Hosp, Adv Lung Dis & Lung Transplant Clin, 618 S Royal St, Falls Church, VA 22314 USA
[2] Inova Fairfax Hosp, Adv Lung Dis Clin, Dept Pharm, Falls Church, VA USA
关键词
BRONCHIOLITIS OBLITERANS SYNDROME; MEDIATED REJECTION; INTERNATIONAL SOCIETY; HLA-ANTIBODIES; HEART;
D O I
10.1016/j.healun.2016.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1057 / 1058
页数:2
相关论文
共 50 条
  • [41] Preemptive treatment with therapeutic plasma exchange and rituximab for early donor-specific antibodies after lung transplantation
    Ius, Fabio
    Sommer, Wiebke
    Tudorache, Igor
    Kuhn, Christian
    Avsar, Murat
    Siemeni, Thierry
    Salman, Jawad
    Hallensleben, Michael.
    Kieneke, Daniela
    Greer, Mark
    Gottlieb, Jens
    Kielstein, Jan T.
    Boethig, Dietmar
    Welte, Tobias
    Haverich, Axel
    Warnecke, Gregor
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (01) : 50 - 58
  • [42] Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients
    Solomon, Sonia
    Colovai, Adriana
    Del Rio, Marcela
    Hayde, Nicole
    PEDIATRIC NEPHROLOGY, 2020, 35 (02) : 261 - 270
  • [43] De Novo Donor-Specific Antibodies after Heart Transplantation: A Comprehensive Guide for Clinicians
    Marco, Irene
    Garcia, Juan Carlos Lopez-Azor
    Martin, Javier Gonzalez
    Sanchez, Andrea Severo
    Carmena, Maria Dolores Garcia-Cosio
    Sierra, Esther Mancebo
    Baguda, Javier de Juan
    Calvo, Javier Castrodeza
    Perez, Francisco Jose Hernandez
    Delgado, Juan Francisco
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [44] Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes
    Gniewkiewicz, Michal
    Czerwinska, Katarzyna
    Zielniok, Katarzyna
    Durlik, Magdalena
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (10)
  • [45] The clinical impact of donor-specific antibodies in heart transplantation
    Barten, Markus J.
    Schulz, Uwe
    Beiras-Fernandez, Andres
    Berchtold-Herz, Michael
    Boeken, Udo
    Garbade, Jens
    Hirt, Stephan
    Richter, Manfred
    Ruhpawar, Arjang
    Sandhaus, Tim
    Schmitto, Jan Dieter
    Schoenrath, Felix
    Schramm, Rene
    Schweiger, Martin
    Wilhelm, Markus
    Zuckermann, Andreas
    TRANSPLANTATION REVIEWS, 2018, 32 (04) : 207 - 217
  • [46] Effect of De novo donor-specific antibodies on graft function in renal allograft recipients
    Singh, Ravi Kumar
    Gupta, Ashwani
    Bhargava, Vinant
    Gupta, Anurag
    Tiwari, Vaibhav
    Bhalla, Manish Malik A. K.
    Rana, D. S.
    Jain, Monika
    INDIAN JOURNAL OF TRANSPLANTATION, 2020, 14 (02) : 130 - 135
  • [47] Impact of donor-specific antibodies on results of liver transplantation
    O'Leary, Jacqueline G.
    Klintmalm, Goeran B.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2013, 18 (03) : 279 - 284
  • [48] Clinical outcomes among renal transplant recipients with pre-transplant weakly reactive donor-specific antibodies
    Yoo, Peter S.
    Bonnel, Alexander
    Kamoun, Malek
    Levine, Matthew H.
    CLINICAL TRANSPLANTATION, 2014, 28 (01) : 127 - 133
  • [49] Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts
    Everly, Matthew J.
    Rebellato, Lorita M.
    Haisch, Carl E.
    Ozawa, Miyuki
    Parker, Karen
    Briley, Kimberly P.
    Catrou, Paul G.
    Bolin, Paul
    Kendrick, William T.
    Kendrick, Scott A.
    Harland, Robert C.
    Terasaki, Paul I.
    TRANSPLANTATION, 2013, 95 (03) : 410 - 417
  • [50] Donor-Specific Antibodies' Meaningful Impact on Liver Transplantation
    Aday, Ariel W.
    O'Leary, Jacqueline G.
    LIVER TRANSPLANTATION, 2018, 24 (08) : 999 - 1000